XBI icon

SPDR S&P Biotech ETF

199 hedge funds and large institutions have $3.15B invested in SPDR S&P Biotech ETF in 2015 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 51 increasing their positions, 71 reducing their positions, and 29 closing their positions.

Holders
199
Holders Change
+3
Holders Change %
+1.53%
% of All Funds
5.23%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.16%
New
37
Increased
51
Reduced
71
Closed
29
Calls
$490M
Puts
$1.2B
Net Calls
-$709M
Net Calls Change
+$110M
Name Market Value Shares Shares
Change
Shares
Change %
FIG
226
Fusion Investment Group
Pennsylvania
-66 Closed
HI
227
Hudock Inc
Pennsylvania
-41 Closed
DCM
228
Dialectic Capital Management
Connecticut
KCM
229
Kingdon Capital Management
New York
PCM
230
Prelude Capital Management
New York
KCM
231
KSA Capital Management
New Jersey
CGH
232
Cleary Gull Holdings
Wisconsin
BC
233
Broadfin Capital
New York
AG
234
Artal Group
Luxembourg
PVI
235
Pura Vida Investments
New York
QF
236
QVT Financial
New York
SC
237
Sculptor Capital
New York
MIG
238
Mariner Investment Group
New York
ST
239
Spot Trading
Illinois
AC
240
Amici Capital
New York
LPU
241
Lansdowne Partners (UK)
United Kingdom
PG
242
PEAK6 Group
Illinois
Nomura Holdings
243
Nomura Holdings
Japan
JGC
244
J. Goldman & Co
New York
DCM
245
Driehaus Capital Management
Illinois
ACP
246
Acuta Capital Partners
California
Parallax Volatility Advisers
247
Parallax Volatility Advisers
California
$0 3
TPCM
248
Tide Point Capital Management
Connecticut
Jennison Associates
249
Jennison Associates
New York
OPPM
250
Opus Point Partners Management
New York